|
Market Closed -
Nasdaq
00:00:00 23/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 9.810 USD | +3.21% |
|
+13.94% | -46.22% |
| 08-06 | ADMA Biologics, Inc., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-06 | Tranche Update on ADMA Biologics, Inc.'s Equity Buyback Plan announced on May 7, 2025. | CI |
| Market Cap | 2.2B 1.92B 1.8B 1.65B 3.09B 210B 3.09B 21.66B 8.36B 107B 8.25B 8.07B 346B | P/E 2026 * |
12.1x | P/E 2027 * | 10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 2.2B 1.92B 1.8B 1.65B 3.09B 210B 3.09B 21.66B 8.36B 107B 8.25B 8.07B 346B | EV / Sales 2026 * |
4.1x | EV / Sales 2027 * | 3.49x |
| Free-Float |
90.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADMA | Delayed | |
CBOE
| ADMA | Real-time |
Last Transcript: ADMA Biologics, Inc.
| 08/12/22 | Wall Street lager gesloten | |
| 07/12/22 | Wall Street koerst af op vlak slot | |
| 07/12/22 | Wall Street verder omlaag bij opening | |
| 07/12/22 | Futures Wall Street wijzen omlaag | |
| 30/03/17 | Chinesischer Investor hat Interesse an Biotest |
| 1 day | +3.21% | ||
| 1 week | +13.94% | ||
| Current month | +4.47% | ||
| 1 month | -0.30% | ||
| 3 months | +14.47% | ||
| 6 months | -31.49% | ||
| Current year | -46.22% |
| 1 week | 8.81 |  | 9.84 |
| 1 month | 8.54 | | 9.91 |
| Current year | 7.21 | | 18.95 |
| 1 year | 7.21 | | 20.46 |
| 3 years | 3.06 | | 25.67 |
| 5 years | 1.01 | | 25.67 |
| 10 years | 1.01 | | 25.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 49 | 01/10/2011 |
Paul Kohler
DFI | Director of Finance/CFO | 49 | 26/02/2026 |
| Compliance Officer | 39 | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Jerrold Grossman
BRD | Director/Board Member | 78 | 01/01/2007 |
Steven Elms
CHM | Chairman | 62 | 30/03/2012 |
Adam Grossman
BRD | Director/Board Member | 49 | 01/01/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/07/26 | Tax | Compliance Officer | -3,177 | 0.0014% | ||
| 16/07/26 | Free | Chief Financial Officer | 221,493 | 0.0956% | ||
| 27/05/26 | Buy | Founder | 6,400 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.21% | +13.94% | -38.80% | +179.49% | 2.2B | |
| +0.72% | +3.85% | +34.96% | -2.54% | 80.27B | |
| +5.56% | +26.98% | +587.35% | +82.58% | 72.88B | |
| -1.07% | +2.47% | -10.62% | -29.36% | 61.51B | |
| -0.78% | -1.49% | -11.82% | +28.69% | 47.39B | |
| +0.66% | +1.72% | +3.39% | +159.99% | 46.58B | |
| +2.87% | +4.25% | +60.22% | -12.54% | 33.3B | |
| +1.83% | +4.26% | +49.81% | +118.47% | 25.73B | |
| +0.19% | +9.99% | +10.75% | +165.38% | 22.88B | |
| +1.04% | +1.96% | +59.16% | +103.91% | 15.82B | |
| Average | +0.94% | +6.79% | +74.44% | +79.41% | 40.86B | |
| Weighted average by Cap. | +0.48% | +7.42% | +119.79% | +52.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 535M 468M 440M 401M 753M 51.18B 753M 5.28B 2.04B 26.14B 2.01B 1.97B 84.26B | 630M 550M 517M 472M 886M 60.18B 886M 6.21B 2.39B 30.73B 2.36B 2.31B 99.08B |
| Net income | 191M 167M 157M 143M 269M 18.29B 269M 1.89B 728M 9.34B 718M 703M 30.11B | 223M 195M 183M 167M 313M 21.29B 313M 2.2B 847M 10.87B 836M 818M 35.05B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/09/26 | $9.810 | +3.21% | 2,737,632 |
| 21/09/26 | $9.505 | +4.34% | 2,859,099 |
| 18/09/26 | $9.110 | +1.79% | 11,401,495 |
| 17/09/26 | $8.950 | +0.56% | 2,131,582 |
| 16/09/26 | $8.900 | +3.37% | 2,766,576 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADMA Stock
Select your edition
All financial news and data tailored to specific country editions
